The newly issued shares would be used for exactly that, a DX deal. These are clearly IPO shares and based on timing of vote, would appear to be scheduled for late December or early January. The series E appears to be from investors that wanted to get their cash in prior to the transaction.
Gerald definitely owes the shareholders an update laying out the exact game plan. Assuming a blog will be out before the market opens Monday.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links